Renin-angiotensin system inhibitors

Papers on renin-angiotensin system inhibitors

120 papers35 new in 30 days

Wednesday, November 18

Tuesday, November 17

Monday, November 9

Saturday, November 7

AHA Scientific Sessions 2026 Abstract

Renin-angiotensin system inhibitors linked to fewer deaths

After catheter-based aortic valve replacement, deaths occurred in 21.9% of people prescribed the drugs versus 27.4% of non-users over a median follow-up of 713 days.After catheter-based aortic valve replacement, deaths occurred in 21.9% of people prescribed the drugs versus 27.4% of non-users over a median follow-up of 713 days.

A replacement aortic valve sits between blue-green figures beside a molecule and gray figures with more white silhouettes among them.

Tuesday, November 3

Monday, November 2

Saturday, October 31

Thursday, October 29

Clinical Kidney Journal

Drug class may be linked to fewer deaths in low-protein kidney disease

Estimated three-year mortality was 14.88% among adults who started renin-angiotensin system inhibitors, versus 18.26% among controls, in an observational study.Estimated three-year mortality was 14.88% among adults who started renin-angiotensin system inhibitors, versus 18.26% among controls, in an observational study.

Figure from Clinical Kidney Journal
Cohort · 10,101 peopleKidney

Tuesday, October 27

Monday, October 26

ESC Congress 2026 Abstract

Three heart drug classes linked to lower risk after valve replacement

Hazard ratios for heart-failure hospitalization or cardiovascular death were 0.93, 0.86 and 0.78 for three drug classes, each compared with no prescription.Hazard ratios for heart-failure hospitalization or cardiovascular death were 0.93, 0.86 and 0.78 for three drug classes, each compared with no prescription.

Cutaway hearts with replacement valves contrast thick dark blue-green muscle with thinner gray walls above a group of small upright people.
Cohort · 57,676 peopleInterventions